Matches in Wikidata for { <http://www.wikidata.org/entity/Q42361424> ?p ?o ?g. }
- Q42361424 description "2016 nî lūn-bûn" @default.
- Q42361424 description "2016年の論文" @default.
- Q42361424 description "2016年論文" @default.
- Q42361424 description "2016年論文" @default.
- Q42361424 description "2016年論文" @default.
- Q42361424 description "2016年論文" @default.
- Q42361424 description "2016年論文" @default.
- Q42361424 description "2016年论文" @default.
- Q42361424 description "2016年论文" @default.
- Q42361424 description "2016年论文" @default.
- Q42361424 description "2016年论文" @default.
- Q42361424 description "2016年论文" @default.
- Q42361424 description "2016年论文" @default.
- Q42361424 description "2016년 논문" @default.
- Q42361424 description "article científic" @default.
- Q42361424 description "article scientific" @default.
- Q42361424 description "article scientifique" @default.
- Q42361424 description "articol științific" @default.
- Q42361424 description "articolo scientifico" @default.
- Q42361424 description "artigo científico" @default.
- Q42361424 description "artigo científico" @default.
- Q42361424 description "artigo científico" @default.
- Q42361424 description "artikel ilmiah" @default.
- Q42361424 description "artikull shkencor" @default.
- Q42361424 description "artikulong pang-agham" @default.
- Q42361424 description "artykuł naukowy" @default.
- Q42361424 description "artículo científico publicado en 2016" @default.
- Q42361424 description "artículu científicu espublizáu en 2016" @default.
- Q42361424 description "bilimsel makale" @default.
- Q42361424 description "bài báo khoa học" @default.
- Q42361424 description "naučni članak" @default.
- Q42361424 description "scienca artikolo" @default.
- Q42361424 description "scientific article published on 30 November 2016" @default.
- Q42361424 description "scientific article published on 30 November 2016" @default.
- Q42361424 description "scientific article published on 30 November 2016" @default.
- Q42361424 description "teaduslik artikkel" @default.
- Q42361424 description "tieteellinen artikkeli" @default.
- Q42361424 description "tudományos cikk" @default.
- Q42361424 description "vedecký článok" @default.
- Q42361424 description "vetenskaplig artikel" @default.
- Q42361424 description "videnskabelig artikel" @default.
- Q42361424 description "vitenskapelig artikkel" @default.
- Q42361424 description "vitskapeleg artikkel" @default.
- Q42361424 description "vědecký článek" @default.
- Q42361424 description "wetenschappelijk artikel" @default.
- Q42361424 description "wissenschaftlicher Artikel" @default.
- Q42361424 description "επιστημονικό άρθρο" @default.
- Q42361424 description "мақолаи илмӣ" @default.
- Q42361424 description "наукова стаття, опублікована в листопаді 2016" @default.
- Q42361424 description "научна статия" @default.
- Q42361424 description "научная статья" @default.
- Q42361424 description "научни чланак" @default.
- Q42361424 description "научни чланак" @default.
- Q42361424 description "מאמר מדעי" @default.
- Q42361424 description "مقالة علمية نشرت في 30 نوفمبر 2016" @default.
- Q42361424 description "৩০ নভেম্বর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q42361424 description "บทความทางวิทยาศาสตร์" @default.
- Q42361424 description "სამეცნიერო სტატია" @default.
- Q42361424 name "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 name "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 type Item @default.
- Q42361424 label "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 label "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 prefLabel "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 prefLabel "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 P1433 Q42361424-45C2B69F-8466-4882-8ADC-04F93E2CA2B5 @default.
- Q42361424 P1476 Q42361424-C127CD44-4774-4164-B17E-04E040F8BEA2 @default.
- Q42361424 P2093 Q42361424-275B57B7-4B54-4309-B26F-0A53B48A7040 @default.
- Q42361424 P2093 Q42361424-3E6C84E8-FC27-4BCE-A058-7F2E105D13E3 @default.
- Q42361424 P2093 Q42361424-5D7FBE9E-1312-44C1-BB05-4AEF4E8C2BAA @default.
- Q42361424 P2093 Q42361424-742D0AC7-683C-4812-8190-16F2586E9C81 @default.
- Q42361424 P2093 Q42361424-9FB4D04B-31E7-4947-90DD-CA97A3B38D49 @default.
- Q42361424 P2093 Q42361424-B4E46DD6-5B44-458F-98C8-D3B714E326BB @default.
- Q42361424 P2093 Q42361424-DC29DDCC-955A-41F6-90C2-CFE02326B0EB @default.
- Q42361424 P2860 Q42361424-1DDC4904-0E2A-4A99-8677-E4F4061EF78D @default.
- Q42361424 P2860 Q42361424-3F0BB1F2-AC53-46B4-A735-76486774083B @default.
- Q42361424 P2860 Q42361424-3F713CCC-7A86-407A-8A0F-1B2267A14F06 @default.
- Q42361424 P2860 Q42361424-43DEC39B-2929-4F7F-9D44-3E72388EDB3C @default.
- Q42361424 P2860 Q42361424-6C33D42F-9038-4BB0-AF2D-0E06E7DD7D53 @default.
- Q42361424 P2860 Q42361424-7F16D8BF-FB09-4270-B6AF-B3D6220ABB29 @default.
- Q42361424 P2860 Q42361424-C2CB04A7-95F8-45FD-BFF1-BF7675AEC926 @default.
- Q42361424 P2860 Q42361424-D809C375-468C-43BB-8A44-11E78697F0EA @default.
- Q42361424 P2888 Q42361424-5CA56582-38A8-490F-90B0-4F8A4B667220 @default.
- Q42361424 P304 Q42361424-1A2E8580-0BCA-4DE0-ADFF-2052118A103A @default.
- Q42361424 P31 Q42361424-E6B10B71-3A7E-4E04-BE75-25C3191A99EB @default.
- Q42361424 P356 Q42361424-52DDEEC2-94F0-4849-A63A-F82FF51840B9 @default.
- Q42361424 P433 Q42361424-C5A87A87-2BEF-4BD3-9232-D2327338CD98 @default.
- Q42361424 P478 Q42361424-CDB723F4-4075-4C1A-961C-E42433E5D1DD @default.
- Q42361424 P50 Q42361424-0F4DA4C4-3EC3-4E13-9719-854545E202C1 @default.
- Q42361424 P50 Q42361424-2251F845-B3B2-463E-B21D-6D6E4755C23B @default.
- Q42361424 P577 Q42361424-26FD52C4-C43D-4CA6-81E3-8CEE615CE64E @default.
- Q42361424 P6179 Q42361424-361562A7-5D72-4CBE-B05B-3DFEC1859A69 @default.
- Q42361424 P698 Q42361424-133B8C36-810C-4953-AB01-5613B590216C @default.
- Q42361424 P921 Q42361424-4AF527B8-D6AB-4989-8C93-1D1116110BA7 @default.
- Q42361424 P932 Q42361424-C445AAAA-5937-4A74-B343-7656C5E20A71 @default.
- Q42361424 P356 S13045-016-0363-1 @default.
- Q42361424 P698 27899158 @default.
- Q42361424 P1433 Q15724593 @default.
- Q42361424 P1476 "High rate of complete responses to immune checkpoint inhibitors in patients with relapsed or refractory Hodgkin lymphoma previously exposed to epigenetic therapy" @default.
- Q42361424 P2093 "Ahmed Sawas" @default.